ReviewCancer management and research2025

Ciltacabtagene Autoleucel for the Treatment of Relapsed/Refractory Multiple Myeloma: Efficacy, Safety, and Place in Therapy.

Utkarsh Goel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.